Barcelona, Spain

Maria Tarragona

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Maria Tarragona: Innovator in Breast Cancer Research

Introduction

Maria Tarragona is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of breast cancer metastasis. With a total of seven patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

Among her latest patents is a method for the diagnosis, prognosis, and treatment of breast cancer metastasis. This invention focuses on determining if the c-MAF gene is amplified in a primary tumor sample. It also includes methods for diagnosing or predicting metastasis in ER-breast cancer and assessing the tendency to develop bone metastasis. Another notable patent involves a method for predicting early bone metastasis in subjects suffering from breast cancer. Additionally, she has developed kits for predicting bone metastasis and clinical outcomes for patients with this condition.

Career Highlights

Maria Tarragona has worked with esteemed organizations such as the Fundació Institut de Recerca Biomèdica (IRB Barcelona) and the Institució Catalana de Recerca i Estudis Avançats. Her research has been pivotal in advancing the understanding of breast cancer and its metastasis.

Collaborations

Some of her notable collaborators include Roger Gomis and Milica Pavlovic. Their combined expertise has contributed to the success of her research initiatives.

Conclusion

Maria Tarragona's innovative work in breast cancer research exemplifies her dedication to improving patient outcomes. Her patents and collaborations highlight her significant role in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…